Reporting owner · CIK 0001977689

Plump Andrew Stewart

Visual SEC Form 4 history across 1 companies, 2 transactions and 2 filings.

PRES, R, DPresident, R&DTAKEDA PHARMACEUTICAL CO LTD
Open-market mix
Filings2Form 4 records
Buying$00 purchases
Selling$2.5M2 sales
Net value−$2.5MBuys minus sells
Companies11 securities
Most recentSep 02, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-51Aug 261Sep 26

Net value flow

Buys minus sells

Aug 26
−$363.3K
Sep 26
−$2.1M

Transaction texture

Ownership and ticket size

Average P/S size$1.3M
Median P/S size$1.3M
Direct0
Indirect2
Sep 02, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at TAKEDA PHARMACEUTICAL CO LTD on Sep 02, 2026 valued at $2,148,372.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at TAKEDA PHARMACEUTICAL CO LTD on Sep 02, 2026 valued at $2,148,372.

Review SEC filing

Associated companies

Visual map of known reporting history

TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
TAKPlump Andrew Stewart
PRESRD
sale10b5-1116k-$214MS0.0%09/0409/02
TAKPlump Andrew Stewart
PRESRD
sale10b5-119.6k-$36.3MS0.8%08/2108/19

Plump Andrew Stewart Insider Activity FAQ

SEC Form 4 context

Who is Plump Andrew Stewart?

Plump Andrew Stewart is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001977689.

Which companies has Plump Andrew Stewart reported transactions for?

TAKEDA PHARMACEUTICAL CO LTD

When was Plump Andrew Stewart's latest insider buy?

No open-market insider purchase is available for this period.

When was Plump Andrew Stewart's latest insider sale?

sale at TAKEDA PHARMACEUTICAL CO LTD on Sep 02, 2026 valued at $2,148,372.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.